Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Upcoming E-conference

No Record Found!!

Startup

Merck Life Science India signs MoU with DPIIT
Merck Life Science India signs MoU with DPIIT
Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Bayer awards incubator opportunity to Genvor
Bayer awards incubator opportunity to Genvor
View More

Digitization

Wipro announces AI Agent Solutions across healthcare industry
Wipro announces AI Agent Solutions across healthcare industry
Amgen opens new technology and innovation site in Hyderabad
Amgen opens new technology and innovation site in Hyderabad
Indegene launches AI platform Cortex
Indegene launches AI platform Cortex
View More

Latest Stories

Cadila launches Cadilose for constipation and hepatic encephalopathy

Glenmark launches nutrition program to fight malnutrition in Philippines

Alembic Pharma and Amlan International partner to advance poultry health in India

Merck inks $200 million deal for Hengrui's midstage heart disease drug

Wipro announces AI Agent Solutions across healthcare industry

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Opinion
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Can India’s pharmaceutical industry achieve self-reliance in APIs? by Chetan Shah, COO, Senores Pharmaceuticals
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging